Cheng Isaac
Insider CIK 1829696 · AVIR Director · AMLX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-06-09 | 2022-06-10 | 19,000 | — | $0 | 19,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-01-06 | 2022-01-10 | 8,400 | — | $0 | 8,400 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-06 | 2022-01-10 | 1,409,035 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-06 | 2022-01-10 | 6,410,964 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-06 | 2022-01-10 | 974,107 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-06 | 2022-01-10 | 1,621,544 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-06 | 2022-01-10 | 1,409,035 | — | $0 | 1,409,035 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | P Buy | 2022-01-06 | 2022-01-10 | 6,578 | $19.00 | $125.0K | 6,578 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-06 | 2022-01-10 | 1,621,544 | — | $0 | 10,415,650 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-06 | 2022-01-10 | 974,107 | — | $0 | 8,794,106 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-06 | 2022-01-10 | 6,410,964 | — | $0 | 7,819,999 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2020-10-29 | 2020-10-30 | 80,000 | — | $0 | 80,000 | SEC↗ |